Visceral leishmaniasis in a patient treated with chemotherapy and radiotherapy for a cavum carcinoma [3];Leishmaniasis visceral en un paciente tratado con quimioterapia y radioterapia por carcinoma de cavum

Medicina Clinica

Volumn 123, Issue 19, 2004, Pages 759-

  Gil Bazo, Ignacio ^a   Pérez Ochoa, Ágata ^a   Panizo Santos, Carlos ^a   Moreno Jiménez, Marta ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTINEOPLASTIC AGENT; DEXAMETHASONE; PHENYTOIN;

ADULT; CASE REPORT; CLINICAL FEATURE; HUMAN; LETTER; LYMPHOEPITHELIOMA; MALE; PANCYTOPENIA; REMISSION; SPLENOMEGALY; VISCERAL LEISHMANIASIS;

EID: 19944427465     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13069313     Document Type: Letter

References (10)

1. Aung L, Gorlick RG, Shi W, Thaler H, Shonter NA, Healy JH, et al. Second malignant neoplasms in long-term survivors of osteosarcoma. Cancer 2002;95:1728-34.
2. Nichols G, De Castro K, Wei LX, Griffin M, Lin N, Oralzi A, et al. Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer. Leukemia 2002;16:1673-9.
3. Guerin PJ, Olliaro P, Sundar S, Boelaert M, Graft SL, Desjeux P, et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002;2:494-501.
4. Fernández-Guerrero ML, Aguado JM, Buzón L, Barros C, Montalban C, Martín T, et al. Visceral leishmaniasis in immunocompromised hosts. Am J Med 1987;83:1098-102.
5. Rodríguez-Wilhelmi P, Panizo C, Ruza E, Rocha E. Tratamiento con anfotericina B liposomal en tres pacientes inmunodeprimidos con leismaniasis visceral. Med Clin (Barc) 2001;116:37-8.
6. Panizo C, Rodríguez-Wilhelmi P, González-Toda V, Cuesta B, Rábago G, Rocha E. First report of visceral leishmaniasis in a orthotopic heart transplant recipient. Transplantation 2000;69:1533-5.
7. Pineda JA, Macias J. Kala-azar en la infeccion por VIH, ¿la punta del iceberg? Med Clin (Barc) 1996;106:697-9.
8. Davidson RN, Di Martino L, Gradoni L, Giacchino R, Russo R, Gaeta GB, et al. Liposomal amphotericin B (AmBisome) in mediterranean visceral leishmaniasis. A multi-centre trial. Q J Med 1994;87:75-81.
9. Thakur CP, Narayan S. A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis. Ann Trop Med Parasitol 2004;98:129-38.
10. Yardley V, Croft SL. A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneus leishmaniasis. Int J Antimicrob Agents 2000;13:243-8.